Top Markets
Coin of the day
Armata Pharmaceuticals, Inc. Armata Pharmaceuticals, Inc.

Armata Pharmaceuticals, Inc.

ARMP
주식 순위 #18294
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology... Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology enterprise with a global focus on creating specialized bacteriophage therapeutics. Its primary objective is to tackle infections that have developed resistance to standard antibiotics. The company's innovative treatments are developed utilizing its exclusive bacteriophage-based technology platform. Within its product pipeline are several significant candidates: AP-SA02, designed for the treatment of Staphylococcus aureus bacteremia; AP-PA02, targeting Pseudomonas aeruginosa; and AP-PA03, intended to address pneumonia. Additionally, Armata has forged a collaborative agreement with Merck & Co. to further the development of synthetic bacteriophage candidates aimed at specific, yet unrevealed, infectious disease agents. The company's main offices are located in Marina del Rey, California.
주가
$5.59
마지막 동기화: 2026-09-02
시가총액
$205.21M
변동 (1일)
6.27%
변동 (1년)
86.33%
국가
US
거래 Armata Pharmaceuticals, Inc. (ARMP)

카테고리

Armata Pharmaceuticals, Inc. (ARMP)의 주가 이력
최고 종가: $5.43 (2026-09-01 기준)

최저 종가: $435.94K (1994-05-01 기준)
Armata Pharmaceuticals, Inc.의 주가 이력 (1994 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) 13.52%
2025 190.05%
2024 -19.95%
2023 58.46%
2022 -67.90%
2021 72.26%
2020 -23.93%
2019 34.77%
2018 -79.83%
2017 -78.80%
2016 -90.19%
2015 -42.27%
2014 -62.10%
2013 143.79%
2012 51.63%
2011 -68.50%
2010 43.56%
2009 25.27%
2008 -87.80%
2007 -70.87%
2006 15.56%
2005 -67.75%
2004 -29.84%
2003 404.64%
2002 -82.93%
2001 -65.33%
2000 120.04%
1999 124.66%
1998 -44.75%
1997 -28.14%
1996 -25.02%
1995 26.21%
1994 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$556.43 40.29%
US
$1.05K 45.39%
NL
$152.82 535.43%
US
$123.05 -8.95%
AU
$757.71 6.76%
CH